Show
Sort by
-
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? : an observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
-
- Journal Article
- A1
- open access
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients : data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients study
-
COPD patients with ventilator-associated pneumonia: implications for management
-
DALI: Defining Antibiotic Levels in Intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients?
-
Update in hospital-acquired bacteremia respiratory infections : experience from the EUROBACT study
-
What's new in invasive pulmonary aspergillosis in the critically ill?
-
Something behind 'age': reply
-
Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients
-
Approach to invasive pulmonary aspergillosis in critically ill patients
-
- Journal Article
- A1
- open access
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients?: data from the multinational DALI study